Clinical Trials Directory

Trials / Terminated

TerminatedNCT01234805

Yoga Therapy in Treating Patients With Malignant Brain Tumors

Yoga and Brain Cancer: A Feasibility Study

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
9 (actual)
Sponsor
Wake Forest University Health Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This clinical trial studies yoga therapy in treating patients with malignant brain tumors. Yoga therapy may improve the quality of life of patients with brain tumors

Detailed description

PRIMARY OBJECTIVES: I. To estimate the participation rate, accrual, adherence, and retention to a yoga trial in patients with malignant brain tumors. SECONDARY OBJECTIVES: I. To obtain estimates of the variability of self-reported fatigue, distress (i.e., depression, anxiety), sleep disturbance, cognitive function, and health-related quality of life from baseline to the end of the intervention at 6 (post-onsite intervention) and 12 weeks (post-full intervention). II. To obtain preliminary estimates of the efficacy of a yoga intervention in patients with malignant brain tumors on the outcomes of fatigue, distress, and cognitive function. III. To standardize the cancer-specific yoga protocol for use with brain tumor patients. OUTLINE: Patients participate in yoga classes comprising postures, deep relaxation, breathing practices, and meditation twice weekly for 75 minutes during weeks 1-6. Patients then practice yoga at home twice weekly for 45 minutes during weeks 7-12. After completion of study treatment, patients are followed up periodically for 4-5 months.

Conditions

Interventions

TypeNameDescription
PROCEDUREyoga therapyParticipates in yoga classes and yoga at home
OTHERquestionnaire administrationAncillary studies
PROCEDUREquality-of-life assessmentAncillary studies

Timeline

Start date
2010-12-01
Primary completion
2012-09-01
Completion
2012-09-01
First posted
2010-11-04
Last updated
2018-07-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01234805. Inclusion in this directory is not an endorsement.